Myriad Genetics Announces Regulatory Approval of the BRACAnalysis® Diagnostic System in Japan for Breast Cancer Patients

    NEXT STORY
    Arvinas Appoints Laurie Smaldone Alsup, M.D., to Board of Directors
    PREV STORY
    Immuron Plans Phase 3 trial for IMM-124E to Prevent Travelers’ Diarrhea
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Aduro Biotech Scientific Advisor and Co-Founder of Aduro Biotech Europe Wiebe Olijve Honored with Royal Decoration

    BERKELEY, Calif. and OSS, Netherlands, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. ...

    author_avatar
    NASDAQ Market News

    Tyme Announces Presentation of Clinical Data on SM-88 in Prostate Cancer at 2018 ASCO Genitourinary Cancers Symposium

    Mack Roach, M.D., FASCO, University of California, San Francisco, to present data from ongoing ...

    author_avatar
    NASDAQ Market News

    PharmaCyte Biotech’s CEO Featured Speaker at Marcum MicroCap Conference

    SILVER SPRING, Md., May 31, 2016 (GLOBE NEWSWIRE) -- PharmaCyte Biotech, Inc. (OTCQB:PMCB), a ...

    author_avatar
    NASDAQ Market News